Immunity and Cancer (U932)

Created in 2005, the INSERM U932 Unit is composed of 10 teams, spread over two buildings (Hôpital Curie and Constant-Burg building, rue Lhomond), with a total of about 120 people.

The teams of our department try to better understand the immune responses, and to direct the immune system to better fight against pathogens and/or tumours. Research projects range from fundamental immunology to translationnal immunology and cancer immunotherapy. These approaches include biology, biochemistry and molecular imaging techniques, based on both in vitro and in vivo experimental models, and immunological monitoring, diagnosis, prognosis and immunotherapy studies in cancer patients.

• Immune responses and cancer (S. AMIGORENA)
• Myeloid cells and immunity (P. BENAROCH)
• Integrative analysis of T cell activation (C. HIVROZ)
• Innate like and CD4+ T cells in cancer (O. LANTZ)
• Spatio-temporal dynamics of immune cells (A.M. LENNON)
• Innate immunity (N. MANEL)
• Translational immunotherapy (E. PIAGGIO)
• Stem cell immunity (E.POIRIER)
• Stroma and immunity (H. SALMON)
• Extracellular vesicles, immune responses and cancer (C. THERY)